Friday, October 24, 2008

Most Promising New MS Treatment Found in Campath?

As researchers continue to investigate more effective and safe treatments, we MS patients will continue to read positive reports of clinical trial results and continue to hope for better treatments and possibly a cure someday. This week was one of those weeks. Positive results from a Phase IIb trial comparing alemtuzumab (Campath-1H) with interferon beta-1a (Rebif) was announced by Genzyme Corporation and Bayer HealthCare Pharmaceuticals.


  1. Lisa--

    This is ironic because my shrink just gave me the two names for this drug yesterday, saying they might be something to look into.

  2. My partner woke me up when she heard about this on BBC radio; I hate to see her get her hopes up...yet.

  3. Here's more that Dr. Coles has said in regard to using Campath in MS patients -

    "I'm sure this is the most effective way to treat MS and it's the best we'll see in terms of efficacy," he added. The trial intentionally focused on patients who were in the early stages of the disease. Longer-term patients are not expected to respond as well to the treatment.

    There's hope, but not as much for more advanced MSers. But the idea that some patients regained some brain volume is pretty cool.

  4. That is cool, and I regained brain volume on no drugs at all. When the "experts" explain that to me, when I'm told where my fist-sized lesion went (again--no drugs), I will be more ready to think "cool."